Amount Raised
83
63
Amount Raised
Growth Score 83 in past quarter
-4 pts
Heat Score 63 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
James Evangelista: Chief Financial Officer
Laurence Lasky: PartnerPast Role: Calithera Biosciences, Led the Firm's Participation
About the Company
The Column Group is a venture capital firm dedicated to creating the next generation of biotechnology companies. They manage over $4 billion in assets and focus on building companies with groundbreaking scientific platforms that have the potential to deliver significant new therapies for unmet medical needs. TCG takes a long-term approach, aiming
to develop companies capable of generating multiple product opportunities rather than focusing on quick exits.